Effectiveness of pharmacist care in the improvement of adherence to antidepressants: A systematic review and meta-analysis

Annals of Pharmacotherapy

Volumn 45, Issue 1, 2011, Pages 39-48

  Rubio Valera, Maria ^a,b   Serrano Blanco, Antoni ^c,d   Magdalena Belío, Jesús ^a,e   Fernández, Ana ^f   García Campayo, Javier ^g   Pujol, Marian March ^h   Hoyo, Yolanda López Del ^h  

^a Research and Development Unit   (Spain)

^b RedIAPP   (Spain)

^c Research and Development Department   (Spain)

^d Letux Health Centre   (Spain)

^e Mental Health Group   (United States)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Depressive disorder; Meta analysis; Patient adherence; Pharmacist services

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DEPRESSION; HUMAN; META ANALYSIS (TOPIC); OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78751548096     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P429     Document Type: Article

References (33)

1. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004;291:2581-90. DOI 10.1001/jama.291.21.2581
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. DOI 10.1371/journal. pmed.0030442
3. Sobocki P, Jonsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ 2006;9:87-98.
4. Crane GE. Iproniazid (marsilid) phosphate, a therapeutic agent for mental disorders and debilitating diseases. Psychiatr Res Rep Am Psychiatr Assoc 1957;8:142-52.
5. Loomer HP, Saunders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc 1957;8:129-41.
6. Depression: the treatment and management of depression in adults (update). National Institute for Health and Clinical Excellence (NHS). National Clinical Practice Guideline 90, 2009. http://guidance.nice.org. uk/CG90 (accessed 2009 Jun 12).
7. Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol 2003;13(suppl 3):S69-75.
8. Lader M. Pharmacotherapy of mood disorders and treatment discontinuation. Drugs 2007;67:1657-63.
9. Resolution ResAP (2001) concerning the pharmacist's role in the framework of health security. Council of Europe, Committee of Ministers. Adopted by the Committee of Ministers on March 21, 2001, at the 76th meeting of the Ministers' Deputies. https://wcd.coe.int/ViewDoc.jsp?id=193721&BackColorInternet= 9999CC&BackColorIntranet=FFBB55&BackColorLogged=FFAC75 (accessed 2009 Jun 12).
10. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
11. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20:1508-16.
12. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and metaanalysis in diabetes management. Ann Pharmacother 2007;41:1569-82. DOI 10.1345/aph.1K151 (Pubitemid 47479786)
13. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and metaanalysis in hypertension management. Ann Pharmacother 2007;41:1770-81. DOI 10.1345/aph.1K311 (Pubitemid 350044338)
14. Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother 2008;42:1195-207. DOI 10.1345/aph.1K618
15. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008;168:687-94. DOI 10.1001/archinte.168.7.687 (Pubitemid 351563951)
16. Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003;23:1634-44.
17. Bower P, Gilbody S, Richards D, Fletcher J, Sutton A. Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry 2006;189:484-93. DOI 10.1192/bjp.bp.106.023655 (Pubitemid 44876866)
18. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longerterm outcomes. Arch Intern Med 2006;166:2314-21. DOI 10.1001/archinte.166.21.2314 (Pubitemid 44833355)
19. Williams JW Jr, Gerrity M, Holsinger T, Dobscha S, Gaynes B, Dietrich A. Systematic review of multifaceted interventions to improve depression care. Gen Hosp Psychiatry 2007;29:91-116. DOI 10.1016/j.genhosppsych.2006.12.003
20. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12. DOI 10.1016/j.jclinepi.2009.06.005
21. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
22. Pasquina P, Tramèr MR, Walder B. Prophylactic respiratory physiotherapy after cardiac surgery: systematic review. BMJ 2003;327:1379. DOI 10.1136/bmj.327.7428.1379
23. Elia N, Tramèr MR. Ketamine and postoperative pain-a quantitative systematic review of randomised trials. Pain 2005;113:61-70. DOI 10.1016/j.pain.2004.09.036 (Pubitemid 40044753)
24. Garcia-Campayo J, Magdalena J, Magallón R, Fernández- García E, Salas M, Andrés E. A meta-analysis of the efficacy of fibromyalgia treatment according to level of care. Arthritis Res Ther 2008;10:R81. DOI 10.1186/ar2455
25. Bungay KM, Adler DA, Rogers WH, et al. Description of a clinical pharmacist intervention administered to primary care patients with depression. Gen Hosp Psychiatry 2004;26:210-8. DOI 10.101/j.genhosppsych.2004.01.004
26. Finley PR, Rens HR, Pont JT, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003;23:1175-85.
27. Adler DA, Bungay KM, Wilson IB, et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry 2004;26:199-209. DOI 10.1016/j.genhosppsych.2003.08.005 (Pubitemid 38581925)
28. Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm 2004;61:364-72.
29. Brook OH, van Hout H, Stalman W, et al. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr Serv 2005;56:487-9. DOI 10.1176/appi.ps.56.4.487 (Pubitemid 40471595)
30. Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: effects on pharmacistpatient collaboration. J Am Pharm Assoc (2003) 2005;45:344-53.
31. Crockett J, Taylor S, Grabham A, Stanford P. Patient outcomes following an intervention involving community pharmacists in the management of depression. Aust J Rural Health 2006;14:263-9. DOI 10.1111/j.1440-1584.2006.00827.
32. Brook O, van Hout H, Niewenhuyse H, Heerdink E. The impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients. Eur Neuropsychopharmacol 2003;13:1-9.
33. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869. DOI 10.1136/bmj.c869